Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  ESSILOR INTL.    EI   FR0000121667

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

ESSILOR INTL. : Essilor Continues to Expand in the United States

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/31/2013 | 06:35am CET

Regulatory News:

Essilor (Paris:EI) is continuing to strengthen its positions in the United States, the world's leading market for ophthalmic lenses, with the acquisition of a lens manufacturer and a new prescription laboratory.

The Company has announced the acquisition of an 80% share in X-Cel Optical, a manufacturer of ophthalmic lenses based in Minnesota (US). Leveraging its widely recognized, high performance technical expertise, X-Cel Optical offers a wide range of niche products, the vast majority of which are bi- and tri-focal, stock and variable-tint lenses. The line-ups are produced in various materials, including Trivex?. With a refraction index of 1.53 and impact resistance comparable to that of polycarbonate, Trivex? is enjoying rapid sales growth.

X-Cel Optical produces just over two million lenses a year and generates full-year revenue of approximately $33 million.

The development of the X-Cel Optical product line, which fits very well with Essilor's, will be led by the Group's various distribution networks in the United States, comprising both proprietary and independent laboratories, and around the world. The X-Cel Optical offer may also be moved upmarket, using Essilor's leading-edge technologies, in particular the Crizal® range of surface coatings, as a lever.

In addition, the partnership will enable Essilor to optimize its sourcing strategy. Lastly, Essilor and X-Cel Optical may also share their engineering skills and capabilities to optimize their production processes.

Essilor is also continuing to deepen its local distribution network in the United States to capture the market's growth potential for value-added lenses. The Company has signed a partnership with Lenstech Optical, a prescription laboratory in Indiana that generates annual revenue of $6 million.

In the future, Essilor will activate the usual value-creation levers by providing Lenstech Optical with new technologies that will speed the distribution of its flagship brands, including Varilux® and Crizal®, in the partner's catchment area.

About Essilor

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates around ?150 million to research and development every year, in a commitment to continuously bring new, more effective products to market. Essilor's flagship brands are Varilux®, Crizal®, Definity®, Xperio®, Optifog? and Foster Grant®. It also develops and markets equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of ?4.2 billion in 2011 and employs around 48,700 people in some 100 countries. It operates 19 plants, a total of 390 prescription laboratories and edging facilities, as well as several research and development centers around the world.

For more information, please visit www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the EuroStoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

Investor Relations and
Financial Communication
Véronique Gillet ? Sébastien Leroy ? Ariel Bauer
Phone: +33 (0)1 49 77 42 16
or
Media Relations
Maïlis Thiercelin
Phone: +33 (0)1 49 77 45 02


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ESSILOR INTL.
12/05 TATA COMMUNICATIONS : expands IZO portfolio with SDWAN
11/29 TATA COMMUNICATIONS : launches IZO SDWAN to enable organisations to unleash thei..
11/25 ESSILOR INTL : Updates 2016 expectations and confirms its robust medium-term out..
11/22 NEWS RELEASE : Essilor Expands in China. Essilor updates 2016 expectations.
11/22 NEWS RELEASE : Essilor Expands in China. Essilor updates 2016 expectations.
10/21 ESSILOR - NEWS RELEASE : Nine-Month Consolidated Revenue up 7.8% at Constant Exc..
10/14 ESSILOR INTL : Bangaloreans Walk in the Dark to eradicate 'preventable' blindnes..
10/14 ESSILOR INTL : Les troubles de la vision touchent 1 Marocain sur 3
10/03 ESSILOR INTL : launches a plan to enable 50% of employees worldwide to become sh..
09/26 ESSILOR INTL : receives the Corporate Social Responsibility Prize from L'AGEFI
More news
Sector news : Glasses, Spectacles & Contact lenses
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Glasses, Spectacles & Contact lenses
News from SeekingAlpha
10/22 Essilor International's (ESLOF) CEO Hubert Sagnières on Q3 2016 Results - Ear..
06/30 Safilo Is Bound To Catch Someone's Eye
2015 THE ISHARES MSCI FRANCE ETF : An Exceptional Fund
2015 Complexities Of Eye Care Drive Strong Moats
Advertisement
Financials (€)
Sales 2016 7 095 M
EBIT 2016 1 268 M
Net income 2016 815 M
Debt 2016 1 794 M
Yield 2016 1,23%
P/E ratio 2016 25,93
P/E ratio 2017 23,12
EV / Sales 2016 3,26x
EV / Sales 2017 2,97x
Capitalization 21 367 M
More Financials
Chart ESSILOR INTL.
Duration : Period :
ESSILOR INTL. Technical Analysis Chart | EI | FR0000121667 | 4-Traders
Full-screen chart
Technical analysis trends ESSILOR INTL.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 120 €
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Hubert Sagnières Chairman & Chief Executive Officer
Paul du Saillant Co-Chief Operating Officer
Laurent Vacherot Co-Chief Operating Officer
Jean Carrier-Guillomet Chief Operating Officer
Géraldine Picaud Chief Financial Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ESSILOR INTL.-14.85%22 779
COOPER COMPANIES INC20.80%7 902
SHANGHAI CONANT OPTICS..--.--%2 081
MENICON CO LTD-22.14%483
INTEROJO CO. LTD.--.--%338
TEARLAB CORP-61.88%28
More Results